Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular β-amyloid deposits in Alzheimer mice

Stem Cells and Development

Volumn 17, Issue 3, 2008, Pages 423-439

  Nikolic, William V ^a   Hou, Huayan ^a   Town, Terrence ^b,e   Zhu, Yuyan ^c   Giunta, Brian ^a   Sanberg, Cyndy D ^c   Zeng, Jin ^a   Luo, Deyan ^a   Ehrhart, Jared ^a   Mori, Takashi ^a,d   Sanberg, Paul R ^a   Tan, Jun ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c Saneron CCEL Therapeutics Inc   (United States)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; CD40 ANTIGEN; CD40 LIGAND; GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN M;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BLOOD CELL; BLOOD LEVEL; BRAIN BLOOD VESSEL; CELL THERAPY; CONTROLLED STUDY; FEMALE; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; MALE; MICROGLIA; MOUSE; NONHUMAN; PARENCHYMA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS, CD40; ASTROCYTES; BLOOD VESSELS; BRAIN; CD40 LIGAND; CELL COUNT; FETAL BLOOD; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MACROPHAGES; MICE; MICE, TRANSGENIC; MICROGLIA; PEPTIDES; PHAGOCYTOSIS; SENILE PLAQUES; TH2 CELLS; TISSUE THERAPY;

MUS; MUS MUSCULUS;

EID: 46749104502     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0018     Document Type: Article

References (83)

1. Benzing WC, JR Wujek, EK Ward, D Shaffer, KH Ashe, SG Younkin and KR Brunden. (1999). Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20:581-589.
2. Bard F, C Cannon, R Barbour, RL Burke, D Games, H Grajeda, T Guido, K Hu, J Huang, K Johnson-Wood, K Khan, D Kholodenko, M Lee, I Lieberburg, R Motter, M Nguyen, F Soriano, N Vasquez, K Weiss, B Welch, P Seubert, D Schenk and T Yednock. (2000). Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature Med 6:916-919.
3. Nicoll JA, D Wilkinson, C Holmes, P Steart, H Markham and RO Weller. (2003). Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nature Med 9:448-452.
4. Schenk D, R Barbour, W Dunn, G Gordon, H Grajeda, T Guido, K Hu, J Huang, K Johnson-Wood, K Khan, D Kholodenko, M Lee, Z Liao, I Lieberburg, R Motter, L Mutter, F Soriano, G Shopp, N Vasquez, C Vandevert, S Walker, M Wogulis, T Yednock, D Games and P Seubert. (1999). Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177.
5. Lim GP, T Chu, F Yang, W Beech, SA Frautschy and GM Cole. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21:8370-8377.
6. Lim GP, F Yang, T Chu, P Chen, W Beech, B Teter, T Tran, O Ubeda, KH Ashe, SA Frautschy and GM Cole. (2000). Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709-5714.
7. Lim GP, F Yang, T Chu, E Gahtan, O Ubeda, W Beech, JB Overmier, K Hsiao-Ashec, SA Frautschy and GM Cole. (2001). Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging 22:983-991.
8. Szekely CA, JE Thorne, PP Zandi, M Ek, E Messias, JC Breitner and SN Goodman. (2004). Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review. Neuroepidemiology 23:159-169.
9. in t' Veld BA, A Ruitenberg, A Hofman, LJ Launer, CM van Duijn, T Stijnen, MM Breteler and BH Stricker. (2001). Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521.
10. Laporte V, G Ait-Ghezala, CH Volmar and M Mullan. (2006). CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models. J Neuroinflammation 3:3.
11. Tan J, T Town, D Paris, T Mori, Z Suo, F Crawford, MP Mattson, RA Flavell and M Mullan. (1999). Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286:2352-2355.
12. Tan J, T Town and M Mullan. (2002). CD40-CD40L interaction in Alzheimer's disease. Curr Opin Pharmacol 2:445-451.
13. Todd Roach J, CH Volmar, S Dwivedi, T Town, R Crescentini, F Crawford, J Tan and M Mullan. (2004). Behavioral effects of CD40-CD40L pathway disruption in aged PSAPP mice. Brain Res 1015:161-168.
14. Town T, J Tan and M Mullan. (2001). CD40 signaling and Alzheimer's disease pathogenesis. Neurochem Int 39:371-380.
15. Tan J, T Town, F Crawford, T Mori, A DelleDonne, R Crescentini, D Obregon, RA Flavell and MJ Mullan. (2002). Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice. Nature Neurosci 5:1288-1293.
16. Calingasan NY, HA Erdely and CA Altar. (2002). Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury. Neurobiol Aging 23:31-39.
17. Togo T, H Akiyama, H Kondo, K Ikeda, M Kato, E Iseki and K Kosaka. (2000). Expression of CD40 in the brain of Alzheimer's disease and other neurological diseases. Brain Res 885:117-121.
18. Desideri G, F Cipollone, S Necozione, C Marini, MC Lechiara, G Taglieri, G Zuliani, R Fellin, A Mezzetti, F di Orio and C Ferri. (2006). Enhanced soluble CD40 ligand and Alzheimer's disease: Evidence of a possible pathogenetic role. Neurobiol Aging 29:348-356.
19. Vendrame M, J Cassady, J Newcomb, T Butler, KR Pennypacker, T Zigova, CD Sanberg, PR Sanberg and AE Willing. (2004). Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 35:2390-2395.
20. El-Badri NS, A Hakki, S Saporta, X Liang, S Madhusodanan, AE Willing, CD Sanberg and PR Sanberg. (2006). Cord blood mesenchymal stem cells: Potential use in neurological disorders. Stem Cells Dev 15:497-506.
21. Garbuzova-Davis S, SJ Gografe, CD Sanberg, AE Willing, S Saporta, DF Cameron, T Desjarlais, J Daily, N Kuzmin-Nichols, W Chamizo, SK Klasko and PR Sanberg. (2006). Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilippo type B mouse model. FASEB J 20:485-487.
22. Henning RJ, JD Burgos, L Ondrovic, P Sanberg, J Balis and MB Morgan. (2006). Human umbilical cord blood progenitor cells are attracted to infarcted myocardium and significantly reduce myocardial infarction size. Cell Transplant 15:647-658.
23. Ende N, R Chen and D Ende-Harris. (2001). Human umbilical cord blood cells ameliorate Alzheimer's disease in transgenic mice. J Med 32:241-247.
24. Garcia-Alloza M, EM Robbins, SX Zhang-Nunes, SM Purcell, RA Betensky, S Raju, C Prada, SM Greenberg, BJ Bacskai and MP Frosch. (2006). Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 24:516-524.
25. Jankowsky JL, HH Slunt, T Ratovitski, NA Jenkins, NG Copeland and DR Borchelt. (2001). Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 17:157-165.
26. Hsiao K, P Chapman, S Nilsen, C Eckman, Y Harigaya, S Younkin, F Yang and G Cole. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
27. Mori T, T Town, J Tan, N Yada, Y Horikoshi, J Yamamoto, T Shimoda, Y Kamanaka, N Tateishi and T Asano. (2006). Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice. J Pharmacol Exp Ther 318:571-578.
28. Tan J, T Town, Z Suo, Y Wu, S Song, A Kundtz, J Kroeger, J Humphrey, F Crawford and M Mullan. (1999). Induction of CD40 on human endothelial cells by Alzheimer's beta-amyloid peptides. Brain Res Bull 50:143-148.
29. Johnson-Wood K, M Lee, R Motter, K Hu, G Gordon, R Barbour, K Khan, M Gordon, H Tan, D Games, I Lieberburg, D Schenk, P Seubert and L McConlogue. (1997). Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94:1550-1555.
30. Rezai-Zadeh K, D Shytle, N Sun, T Mori, H Hou, D Jeanniton, J Ehrhart, K Townsend, J Zeng, D Morgan, J Hardy, T Town and J Tan. (2005). Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J Neurosci 25:8807-8814.
31. Town T, M Vendrame, A Patel, D Poetter, A DelleDonne, T Mori, R Smeed, F Crawford, T Klein, J Tan and M Mullan. (2002). Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42). J Neuroimmunol 132:49-59.
32. Nikolic WV, Y Bai, D Obregon, H Hou, T Mori, J Zeng, J Ehrhart, RD Shytle, B Giunta, D Morgan, T Town and J Tan. (2007). Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage. Proc Natl Acad Sci USA 104:2507-2512.
33. Townsend KP, T Town, T Mori, LF Lue, D Shytle, PR Sanberg, D Morgan, F Fernandez, RA Flavell and J Tan. (2005). CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur J Immunol 35:901-910.
34. Ellis RJ, JM Olichney, LJ Thal, SS Mirra, JC Morris, D Beekly and A Heyman. (1996). Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 46:1592-1596.
35. Christie R, M Yamada, M Moskowitz and B Hyman. (2001). Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. Am J Pathol 158:1065-1071.
36. Friedlich AL, JY Lee, T van Groen, RA Cherny, I Volitakis, TB Cole, RD Palmiter, JY Koh and AI Bush. (2004). Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease. J Neurosci 24:3453-3459.
37. Kim J, L Onstead, S Randle, R Price, L Smithson, C Zwizinski, DW Dickson, T Golde and E McGowan. (2007). Abeta40 inhibits amyloid deposition in vivo. J Neurosci 27:627-633.
38. Li L, D Cao, DW Garber, H Kim and K Fukuchi. (2003). Association of aortic atherosclerosis with cerebral beta-amyloidosis and learning deficits in a mouse model of Alzheimer's disease. Am J Pathol 163:2155-2164.
39. Robbins EM, RA Betensky, SB Domnitz, SM Purcell, M Garcia-Alloza, C Greenberg, GW Rebeck, BT Hyman, SM Greenberg, MP Frosch and BJ Bacskai. (2006). Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci 26:365-371.
40. Frackowiak J, HM Wisniewski, J Wegiel, GS Merz, K Iqbal and KC Wang. (1992). Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils. Acta Neuropathol (Berl) 84:225-233.
41. Potter H, IM Wefes and LN Nilsson. (2001). The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation. Neurobiol Aging 22:923-930.
42. Tan J, T Town, D Paris, A Placzek, T Parker, F Crawford, H Yu, J Humphrey and M Mullan. (1999). Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis. J Neuroimmunol 97:77-85.
43. Tan J, T Town, M Saxe, D Paris, Y Wu and M Mullan. (1999). Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol 163:6614-6621.
44. Grewal IS and RA Flavell. (1998). CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111-135.
45. Mackey MF, RJ Barth, Jr. and RJ Noelle. (1998). The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63:418-428.
46. Newman MB, AE Willing, JJ Manresa, CD Sanberg and PR Sanberg. (2006). Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol 199:201-208.
47. DeMattos RB, KR Bales, DJ Cummins, SM Paul and DM Holtzman. (2002). Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295:2264-2267.
48. Carson MJ, CR Reilly, JG Sutcliffe and D Lo. (1998). Mature microglia resemble immature antigen-presenting cells. Glia 22:72-85.
49. Chen K, J Huang, W Gong, L Zhang, P Yu and JM Wang. (2006). CD40/CD40L dyad in the inflammatory and immune responses in the central nervous system. Cell Mol Immunol 3:163-169.
50. Tan J, T Town and M Mullan. (2000). CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway. J Biol Chem 275:37224-37231.
51. Ponomarev ED, LP Shriver and BN Dittel. (2006). CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J Immunol 176:1402-1410.
52. Lue LF and DG Walker. (2002). Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide. J Neurosci Res 70:599-610.
53. Selkoe DJ. (2001). Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81:741-766.
54. Jellinger KA. (2002). Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm 109:813-836.
55. Selkoe DJ. (2001). Clearing the brain's amyloid cobwebs. Neuron 32:177-180.
56. Vinters HV and ES Farag. (2003). Amyloidosis of cerebral arteries. Adv Neurol 92:105-112.
57. Malinin NL, S Wright, P Seubert, D Schenk and I Griswold-Prenner. (2005). Amyloid-beta neurotoxicity is mediated by FISH adapter protein and ADAM12 metalloprotease activity. Proc Natl Acad Sci USA 102:3058-3063.
58. Eikelenboom P and WA van Gool. (2004). Neuroinflammatory perspectives on the two faces of Alzheimer's disease. J Neural Transm 111:281-294.
59. Rozemuller AJ, WA van Gool and P Eikelenboom. (2005). The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications. Curr Drug Targets CNS Neurol Disord 4:223-233.
60. Crossgrove JS, GJ Li and W Zheng. (2005). The choroid plexus removes beta-amyloid from brain cerebrospinal fluid. Exp Biol Med (Maywood) 230:771-776.
61. DeMattos RB, KR Bales, M Parsadanian, MA O'Dell, EM Foss, SM Paul and DM Holtzman. (2002). Plaque-associated disruption of CSF and plasma amyloid-beta (Abeta) equilibrium in a mouse model of Alzheimer's disease. J Neurochem 81:229-236.
62. Shibata M, S Yamada, SR Kumar, M Calero, J Bading, B Frangione, DM Holtzman, CA Miller, DK Strickland, J Ghiso and BV Zlokovic. (2000). Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106:1489-1499.
63. Shiiki T, S Ohtsuki, A Kurihara, H Naganuma, K Nishimura, M Tachikawa, K Hosoya and T Terasaki. (2004). Brain insulin impairs amyloid-beta(1-40) clearance from the brain. J Neurosci 24:9632-9637.
64. Terasaki T and S Ohtsuki. (2005). Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology. NeuroRx 2:63-72.
65. Suo Z, J Tan, A Placzek, F Crawford, C Fang and M Mullan. (1998). Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. Brain Res 807:110-117.
66. Wyss-Coray T, P Borrow, MJ Brooker and L Mucke. (1997). Astroglial overproduction of TGF-beta 1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 77:45-50.
67. Wyss-Coray T, C Lin, F Yan, GQ Yu, M Rohde, L McConlogue, E Masliah and L Mucke. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nature Med 7:612-618.
68. Vendrame M, C Gemma, D de Mesquita, L Collier, PC Bickford, CD Sanberg, PR Sanberg, KR Pennypacker and AE Willing. (2005). Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14:595-604.
69. McGowan E, S Sanders, T Iwatsubo, A Takeuchi, T Saido, C Zehr, X Yu, S Uljon, R Wang, D Mann, D Dickson and K Duff. (1999). Amyloid phenotype characterization of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes. Neurobiol Dis 6:231-244.
70. Suen Y, SM Lee, J Schreurs, E Knoppel and MS Cairo. (1994). Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: altered posttranscriptional stability. Blood 84:4269-4277.
71. Borlongan CV, M Hadman, CD Sanberg and PR Sanberg. (2004). Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35:2385-2389.
72. Sanberg PR, AE Willing, S Garbuzova-Davis, S Saporta, G Liu, CD Sanberg, PC Bickford, SK Klasko and NS El-Badri. (2005). Umbilical cord blood-derived stem cells and brain repair. Ann NY Acad Sci 1049:67-83.
73. Kakimura J, Y Kitamura, K Takata, M Umeki, S Suzuki, K Shibagaki, T Taniguchi, Y Nomura, PJ Gebicke-Haerter, MA Smith, G Perry and S Shimohama. (2002). Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins. FASEB J 16:601-603.
74. Koenigsknecht-Talboo J and GE Landreth. (2005). Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J Neurosci 25:8240-8249.
75. Quan N and WA Banks. (2007). Brain-immune communication pathways. Brain Behav Immun 21:727-735.
76. Simard AR, D Soulet, G Gowing, JP Julien and S Rivest. (2006). Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49:489-502.
77. Paresce DM, RN Ghosh and FR Maxfield. (1996). Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17:553-565.
78. Paresce DM, H Chung and FR Maxfield. (1997). Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J Biol Chem 272:29390-29397.
79. Chung H, MI Brazil, TT Soe and FR Maxfield. (1999). Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem 274:32301-32308.
80. Imrich H and K Harzer. (2001). On the role of peripheral macrophages during active experimental allergic encephalomyelitis (EAE). J Neural Transm 108:379-395.
81. Priller J, A Flugel, T Wehner, M Boentert, CA Haas, M Prinz, F Fernandez-Klett, K Prass, I Bechmann, BA de Boer, M Frotscher, GW Kreutzberg, DA Persons and U Dirnagl. (2001). Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment. Nature Med 7:1356-1361.
82. Town T, V Nikolic and J Tan. (2005). The microglial " activation" continuum: from innate to adaptive responses. J Neuroinflammation 2:24.
83. Town T, J Tan, RA Flavell and M Mullan. (2005). T-cells in Alzheimer's disease. Neuromolecular Med 7:255-264.